VIRGINIA BEACH, Va., Sept. 16, 2016 /PRNewswire-USNewswire/ -- The United States Court of Appeals for the Federal Circuit upheld a Virginia federal jury award to LifeNet Health® of $34.7 million in damages for LifeCell® Corp.'s infringement of a LifeNet Health patent related to improving the preservation of tissue grafts.
In November 2014, the jury found that LifeCell's AlloDerm® Ready to Use Regenerative Tissue Matrix and Strattice™ skin graft products infringed all seven asserted claims of LifeNet Health's patent. The LifeCell products are typically used in abdominal wall repair, breast reconstruction, and orthopedic surgical procedures.
Douglas B. Wilson, LifeNet Health's Executive Vice President said, "We're happy to have the Federal Circuit affirm the jury's verdict and recognize the value of LifeNet Health's technology and look forward to development of future technologies that help further its goals of saving lives, restoring health and giving hope."
About LifeNet Health LifeNet Health helps save lives, restore health, and give hope to thousands each year. It is the world's most trusted provider of transplant solutions — from organ procurement to bio-implants and cellular therapies — and a leader in regenerative medicine, while always honoring the donors and healthcare professionals who enable healing. For more information about LifeNet Health, go to www.LifeNetHealth.org.